St Jude Medical Announces Positive Results from Portico Heart Valve Study

St. Jude Medical

today announced positive results for the 23 and 25 mm Portico™ Transcatheter Aortic Heart Valves in the Portico Transfemoral CE Mark Trial (Portico TF CE Trial). Patients enrolled in the study experienced a significant improvement in valve function at 30 days. The preliminary findings indicate exceptional hemodynamic performance (the ability to maximize blood flow) and improvement in the severity of heart failure symptoms as measured by the New York Heart Association (NYHA) Functional Classification System. The data was presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. Image of the 23 mm Portico(TM) Transcatheter Aortic Heart Valve, one of